SCHEMBL9730400

SCHEMBL9730400

O=Cc1ccccc1-c1ccc([N+](=O)[O-])c(CCl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
TSHR P16473 1/20 0.50
ERN1 O75460 7/20 0.40
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 1/20 0.37
SOS1 Q07889 1/20 0.37
XDH P47989 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
STAT6 P42226 1/20 0.35
HIF1A Q16665 1/20 0.35
PHLPP2 Q6ZVD8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9798217 0.86 ERN1 (0.43) ALDH1A1TSHRERN1HTTLMNA
SCHEMBL4273991 0.79 VCAM1 (0.54) ALDH1A1ERN1HTTLMNA
SCHEMBL9664960 0.76 TDP1 (0.60) ALDH1A1TSHRERN1LMNATDP1
SCHEMBL2556452 0.74 ERN1 (0.50) ALDH1A1ERN1TDP1
SCHEMBL28811341 0.73 DPP4 (0.42) ALDH1A1ERN1HTTLMNASMN1; SMN2
SCHEMBL9798503 0.73 ALDH1A1 (0.34) ALDH1A1HTTHPGDCYP1A2CYP3A4
SCHEMBL9192573 0.73 ALDH1A1 (0.40) ALDH1A1ERN1TDP1SOS1TP53
SCHEMBL7907202 0.71 ALDH1A1 (0.51) ALDH1A1ERN1LMNASMN1; SMN2TDP1
SCHEMBL4281290 0.71 L3MBTL1 (0.56) ALDH1A1TDP1HPGDMAPK1
SCHEMBL6210201 0.71 ERN1 (0.58) ALDH1A1ERN1HTTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5120845-A Treating congestive heart failure JANSSEN PHARMACEUTICA N.V. (BE) 1992-06-09 US disclosed
US-5043327-A Treating mammals with congestive heart failure JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-27 US disclosed